The 20th annual Oxford International Conference on the Science of Botanicals is now accepting abstract submissions. The event is held March 30th - April 2nd, 2020 in Oxford, Mississippi.
A Colorado-based producer of bulk hemp-derived CBD products, backed by an ambitious state government plan, is looking south to new markets in Latin America.
A rush to market for CBD has left the terpenes in hemp out in the cold. An expert in the space said there is much potential benefit yet to be discovered in these fractions of the plant.
Hemp cultivation will ramp up markedly according to a new report, raising questions of whether the supply cart is getting ahead of the processing horse.
A new poll shows many consumers would stop using CBD products if they knew FDA has not yet set regulations around them. The poll was commissioned by the Natural Products Association.
The United Natural Products Alliance has announced a new policy on hemp extracts while at the same time announcing its first member engaged exclusively in the business.
FDA warned pregnant and breast-feeding women yesterday to avoid CBD, THC and marijuana in any form, including the proliferation of food, supplements and cosmetics containing CBD and other cannabis-derived ingredients that currently are flooding the market...
The inauguration of a huge, shiny, new (well, repurposed) facility leads to the question of what scale in the industry best serves the dietary supplement consumer.
Yesterday four trade associations representing the dietary supplement industry sent a letter to all 535 members of the US Congress urging them to make CBD a legal dietary ingredient and to give FDA the resources to regulate the sector.
Neptune Wellness Solutions has entered into an equity partnership with a media company to drive the visibility of its hemp-derived CBD products in the US market.
As widely predicted, the plaintiff’s bar has turned its attention to the burgeoning CBD category with a series of lawsuits alleging that products contain “significantly lower levels of CBD than advertised.”
FDA is continuing to crack down on the legality of CBD when a case comes across its desk, despite a call for an official enforcement discretion policy.
